Method signals
The most useful material explains how the method performs, where it fails and what assumptions sit inside the workflow.
BEAM-101
BEAM-101 sits at the intersection of biotech practice, technical proof and decisions readers can verify.
In the GenoMethods index, BEAM-101 is treated as a signal-bearing subject, not a label.
The lens is deliberately method-first: assays, cohorts, models, reagents, pipelines and validation choices are not background details; they shape the conclusion.
As the field moves, this page will help separate durable advances from temporary attention, with the wider context collected under Gene Editing.
How we read the field
Practical thresholds
A claim becomes stronger when it survives comparison, scale, safety review and routine use beyond the first demonstration.
Why it matters now
The first test is whether BEAM-101 changes what researchers, clinicians, builders or patients can decide with more confidence.